spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BIO-Europe Spring 2018

12-14 March 2018
RAI Amsterdam, Europaplein, NL 1078 GZ, Amsterdam

The twelfth annual BIO-Europe Spring®conferenceis the premier springtime partnering conference for the biotechnology industry. For its 2018 edition, BIO-Europe Spring comes to Amsterdam, The Netherlands on March 12–14, 2018.

Theconference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and experience how you can have more partnering meetings in the three days of the conference than in the rest of the year.

Based on attendance at previous events, BIO-Europe Spring 2018 will bring together close to 2,600 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in over 15,000 partnering meetings.

 

Program please see website:  https://ebdgroup.knect365.com/bioeurope-spring/agenda/2

 
Print this page
Send to a friend
   
spacer
Industry Events

Synthetic Biology Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

Banner of PHPL West Coast_events_95 on Samedan Banner of Cell_Analysis_Oxford_events_97 on Samedan

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>


News and Press Releases

Laboratory Gains ISO 17025 Accreditation for Transit Simulation

Medical Engineering Technologies’ packaging laboratory now has ISTA 2A and ASTM D4169 transit testing added to its accreditation.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement